Engineering challenges in immunobarrier device development

Principles of Tissue Engineering, Third Edition

Volumn , Issue , 2007, Pages 405-418

  Lewis, AmyS ^a   Colton, Clark K ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885128044     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012370615-7/50033-0     Document Type: Chapter

References (55)

1. P. Aebischer, M. Schluep, N. Deglon, J.-M. Joseph, L. Hirt, B. Heyd, M. Goddard, J.P. Hammang, A.D. Zurn, A.C. Kato, et al. (1996) Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 2(6), 696-699
2. T. Aoki, H. Hui, Y. Umehara, S. LiCalzi, A.A. Demetriou, J. Rozga and R. Perfetti (2005) Intrasplenic transplantation of encapsulated genetically engineered mouse insulinoma cells reverses streptozotocininduced diabetes in rats. Cell Transplant. 14 411-421
3. E.S. Avgoustiniatos (2001) Oxygen Diffusion Limitations in Pancreatic Islet Culture and Immunoisolation. PhD Thesis MA: M.I.T., Cambridge
4. E.S. Avgoustiniatos and C.K. Colton (1997) Design considerations in immunoisolation. R. Lanza, R. Langer, W. Chick (Eds) Principles of Tissue Engineering 333-346
5. R.G. Landes, TX Austin, E.S. Avgoustiniatos and C.K. Colton (1997) Effect of external oxygen mass transfer resistance on viability of immunoisolated tissue. Ann. N.Y. Acad. Sci. 831 145-167
6. E.S. Avgoustiniatos, H. Wu and C.K. Colton (2000) Engineering challenges in immunoisolation device development. R.P. Lanza, R. Langer, J. Vacanti (Eds) Principles of Tissue Engineering 2nd ed. San Diego: Academic Press 331-350
7. A.E. Bailey (1979) Bailey's Industrial Oil and Fat Products. New York: Wiley
8. J. Bloch, A.C. Bachoud-Levi, N. Deglon, J.P. Lefaucheur, L. Winkel, S. Palfi, J.P. Nguyen, C. Bourdet, V. Gaura, et al., P. Remy (2004) Neuroprotective gene therapy for Huntington's disease, using polymerencapsulated cells engineered to secrete ciliary neurotrophic factor: results of a phase I. Hum. Gene Ther. 15 968-975
9. J. Brauker, V. Carr-Brendel, L. Martinson, J. Crudele, W. Johnston and R.C. Johnson (1995) Neovascularization of synthetic membranes directed by membrane microarchitecture. J. Biomed. Mater. Res. 29(12), 1517-1524
10. J. Brauker, G.H. Frost, V. Dwarki, T. Nijjar, R. Chin, V. Carr-Brendel, C. Jasunas, D. Hodgett, W. Stone, L.K. Cohen, et al. (1998) Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents. Hum. Gene Ther. 9 879-888
11. E. Buchser, M. Goddard, B. Heyd, J.M. Joseph, J. Favre, T.N. de Tribolet N., M. Lysaght and P. Aebischer (1996) Immunoisolated xenogeneic chromaffin cell therapy for chronic pain: initial clinical experience. Anesthesiology 85(5), 1005-1012
12. R. Calafiore, G. Basta, G. Luca, M. Calvitti, G. Calabrese, L. Racanicchi, G. Macchiarulo, F. Mancusso, L. Guido and P. Brunetti (2004) Grafts of microencapsulated pancreatic islet cells for the therapy of diabetes melliltus in nonimmunosuppressed animals. Biotechnol. Appl. Biochem. 39 159-164
13. R. Calafiore, G. Basta, G. Luca, A. Lemmi, L. Racanicchi, F. Mancuso, M.P. Montanucci and P. Brunetti (2006) Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant. Proc. 38 1156-1157
14. F. Cellesi, W. Weber, M. Fussenegger, J.A. Hubbell and N. Tirelli (2004) Towards a fully synthetic substitute of alginate: optimization of a thermal gelation/chemical cross-linking scheme (“tandem” gelation) for the production and liquid-core capsules. Biotechnol. Bioeng. 88(6), 740-749
15. S.Y. Chae, Y.Y. Kim, S.W. Kim and Y.H. Bae (2004) Prolonged glucose normalization of streptozotocin-induced diabetic mice by transplantation of rat islets coencapsulated with crosslinked hemoglobin. Transplantation 78(3), 392-397
16. S.Y. Chae, M. Lee, S.W. Kim and Y.H. Bae (2004) Protection of insulin-secreting cells from nitric oxide-induced cellular damage by cross-linked hemoglobin. Biomaterials 25 843-850
17. C.K. Colton (1995) Implantable biohybrid artificial organs. Cell Transplant. 4(4), 415-436
18. C.K. Colton and E.S. Avgoustiniatos (1991) Bioengineering in development of the hybrid artificial pancreas. J. Biomech. Eng. 113 152-170
19. G.M. De Groot M., T.A. Schuurs, P.P.M. Keizer, S. Fekken, H.G.D. Leuvenink and R. van Schilfgaarde (2003) Response of encapsulated rat pancreatic islets to hypoxia. Cell Transplant. 12 867-875
20. T.A. Desai, T. West, M. Cohen, T. Boiarski and A. Rampersaud (2004) Nanoporous microsystems for islet cell replacement. Adv. Drug Del. Rev. 56 1661-1673
21. V.P. De Vos P., J.F.M. van Straaten, A.G. Nieuwenhuizen, G.M. de Groot M., R.J. Ploeg, H.B.J. De Haan B.J. and R. van Schilfgaarde (1999) Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 48(7), 1381-1388
22. V.P. De Vos P., H.B.J. De Haan B.J., H.A. De Haan A., J. van Zanten and M.M. Faas (2004) Factors influencing functional survival of microencapsulated islet grafts. Cell Transplant. 13 515-524
23. K.E. Dionne, C.K. Colton and M.L. Yarmush (1993) Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 42 12-21
24. B. Fillion and B.I. Morsi (2000) Gas-liquid mass-transfer and hydrodynamic parameters in a soybean oil hydrogenation process under industrial conditions. Ind. Eng. Chem. Res. 39 2157-2168
25. C. Hasse, G. Klock, A. Schlosser, U. Zimmermann and M. Rothmund (1997) Parathyroid allotransplantation without immunosuppression. Lancet North Am. Ed. 350 1296-1297
26. O. Hauser, E. Prieschl-Grassauer and B. Salmons (2004) Encapsulated, genetically modified cell producing in vivo therapeutics. Curr. Opin. Mol. Ther. 6(4), 412-420
27. H. Kishima, T. Poyot, J. Bloch, J. Dauguet, F. Conde, F. Dolle, F. Hinnen, W. Pralong, S. Palfi, N. Deglon, et al. (2004) Encapsulated GDNFproducing C2C12 cells for Parkinson's disease: a preclinical study in chronic MPTP-treated baboons. Neurobiol. Dis. 16 428-439
28. T. Kobayashi, G. Harb and G.R. Rayat (2005) Prolonged survival of microencapsulated neonatal porcine islets in mice treated with a combination of anti-CD154 and anti-LFA-1 monoclonal antibodies. Transplantation 80(6), 821-827
29. O. Korsgren and J. Jansson (1994) Porcine islet-like cell clusters cure diabetic nude rats when transplanted under the kidney capsule, but not when implanted into the liver or spleen. Cell Transplant. 3 49-54
30. K.E. La Flamme, G. Mor, D. Gong, T.T. La Tempa T., V.A. Fusaro, C.A. Grimes and T.A. Desai (2005) Nanoporous alumina capsules for cellular macroencapsulation: transport and biocompatibility. Diabetes Technol. Ther. 7(5), 684-694
31. A. Leung, Y. Ramaswamy, P. Munro, G. Lawrie, L. Nielsen and M. Trau (2005) Emulsion strategies in the microencapsulation of cells: pathways to thin coherent membranes. Biotechnol. Bioeng. 92 45-53
32. A.S. Lewis and C.K. Colton (2005) Tissue engineering for insulin replacement in diabetes. P.X. Ma, J. Elisseeff (Eds) Scaffolding in Tissue Engineering Boca Raton, FL: Taylor &Francis 575-598
33. S. Matsumoto and Y. Kuroda (2002) Perfluorocarbon for organ preservation before transplantation. Transplantation 74(12), 1804-1809
34. J.D. McMillan and D.I.C. Wang (1990) Mechanisms of oxygen transfer enhancement during submerged cultivation in perfluorochemicalin-water dispersions. Ann. N.Y. Acad. Sci. 589 283-300
35. A. Omer, M. Keegan, E. Czismadia, V.P. De Vos P., N. van Rooijen, S. Bonner-Weir and G.C. Weir (2003) Macrophage depletion improves survival of porcine neonatal pancreatic cell clusters contained in alginate macrocapsules transplanted into rats. Xenotransplantation 10 240-251
36. A. Omer, V. Duvivier-Kali, J. Fernandes, V. Tchipashvili, C.K. Colton and G.C. Weir (2005) Long-term normoglycemia in rats receiving transplants with encapsulated islets. Transplantation 79(1), 52-58
37. G. Orive, R.M. Hernandez, A.R. Gascon, R. Calafiore, T.M.S. Chang, V.P. de Vos P., G. Hortelano, D. Hunkeler, I. Lacik and J.L. Pedraz (2004) History, challenges and perspectives of cell microencapsulation. Trends Biotechnol. 22(2), 87-92
38. D. Poncelet, R. Leung, L. Centomo and R.J. Neufeld (1993) Microencapsulation of silicone oils within polyacrylamide-polyethylene membranes as oxygen carriers for bioreactor oxygenation. J. Chem. Technol. Biot. 57 253-263
39. E. Rafael, G.S. Wu, K. Hultenby, A. Tibell and A. Wernerson (2003) Improved survival of macroencapsulated islets of Langerhans by preimplantation of the immunoisolating device: a morphometric study. Cell Transplant. 12 407-412
40. E.A. Ryan, B.W. Paty, P.A. Senior, D. Bigam, E. Alfadhli, N.M. Kneteman, J.R.T. Lakey and A.M.J. Shapiro (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54 2060-2069
41. S.A. Safley, L.M. Kapp, C. Tucker-Burden, B. Hering, J.A. Kapp and C.J. Weber (2005) Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways. Transplantation 79(4), 409-417
42. S. Schneider, P.J. Feilen, F. Brunnenmeier, T. Minnemann, H. Zimmermann, U. Zimmermann and M.M. Weber (2005) Longterm graft function of adult rat and human islets encapsulated in novel alginate-based microcapsules after transplantation in immunocompetent diabetic mic. Diabetes 54 687-693
43. F.K. Schweighardt and C.R. Kayhart (1990) Concentrated Stable Fluorochemical Aqueous Emulsions Containing Triglycerides. United States, Patent 4, 895
44. F.K. Schweighardt and C.R. Kayhart (1990) Concentrated Stable Fluorochemical Aqueous Emulsions Containing Triglycerides. United States, Patent 4, 876
45. F. Schwenter, B.L. Schneider, W.F. Pralong, N. Deglon and P. Aebischer (2004) Survival of encapsulated human primary fibroblasts and erythropoietin expression under xenogeneic con ditions. Hum. Gene Ther. 15 669-689
46. N.E. Simpson, N. Khokhlova, J.A. Oca-Cossio, S.S. McMarlane, C.P. Simpson and I. Constantinidis (2005) Effects of growth regulation on conditionally transformed alginate-entrapped insulinsecreting cell lines in vitro. Biomaterials 26 4633-4641
47. I.F. Tannock (1972) Oxygen diffusion and the distribution of cellular radiosensitivity in tumors. Br. J. Radiol. 45 515-524
48. M.K. Tham, R.D. Walker and J.H. Modell (1973) Diffusion coefficients of O 2, N 2 and CO 2 in fluorinated ethers. J. Chem. Eng. Data 18 411-412
49. C. Toso, Z. Mathe, P. Morel, J. Oberholzer, D. Bosco, D. Sainz-Vidal, D. Hunkeler, L.H. Buhler, C. Wandrey and T. Berney (2005) Effect of microcapsule composition and short-term immuno suppression on intraportal biocompatibility. Cell Transplant. 14 159-167
50. N. Trivedi, G.M. Steil, C.K. Colton, S. Bonner-Weir and G.C. Weir (2000) Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant. 9 115-124
51. F. Wiegand, K.-D. Kroncke and V. Kolb-Bachofen (1993) Macrophagegenerated nitric oxide as cytotoxic factor in destruction of alginateencapsulated islets. Transplantation 56(5), 1206-1212
52. H. Wu, E.S. Avgoustiniatos, L. Swette, S. Bonner-Weir, G.C. Weir and C.K. Colton (1999) In situ electrochemical oxygen generation with an immunoisolated device. Ann. N.Y. Acad. Sci. 875 105-125
53. T. Zekorn, U. Siebers, R.G. Bretzel, S. Heller, U. Meder, H. Ruttkay, U. Zimmermann and K. Federlin (1991) Impact of the perfluorochemical FC43 on function of isolated islets. Horm. Metab. Res. 23 302-303
54. T. Zekorn, U. Siebers, A. Horcher, R. Schnettler, U. Zimmermann, R.G. Bretzel and K. Federlin (1992) Alginate coating of islets of Langerhans: in vitro studies on a new method for microencapsulation for immuno-isolated transplantation. Acta Diabetol. 29 41-45
55. U. Zimmermann, U. Noth, P. Grohn, A. Jork, K. Ulrichs, J. Lutz and A. Haase (2000) Noninvasive evaluation of the location, the functional integrity, and the oxygen supply of implants: 19F nuclear magnetic resonance imaging of perfluorocarbo Ba2+-alginate beads. Artif. Cells Blood Substit. Immobil. Biotechnol. 28(2)